Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Investigation of Clinically Significant Molecular Aberrations in Patients with Prostate Cancer: Implications for Personalized Treatment, Prognosis and Genetic Testing.
Fountzilas E, Kouspou M, Eliades A, Papadopoulou K, Bournakis E, Goussia A, Tsiatas M, Achilleos A, Tsangaras K, Billioud G, Loizides C, Lemesios C, Kypri E, Ioannides M, Koumbaris G, Levva S, Vakalopoulos I, Paliouras A, Pervana S, Koinis F, Bumci R, Christopoulou A, Meditskou S, Psyrri A, Boukovinas I, Visvikis A, Karavasilis V, Koukoulis GK, Kotsakis A, Giannakis D, Fountzilas G, Patsalis PC. Fountzilas E, et al. Among authors: koinis f. Int J Mol Sci. 2023 Jul 23;24(14):11834. doi: 10.3390/ijms241411834. Int J Mol Sci. 2023. PMID: 37511593 Free PMC article.
Emerging Role of YAP and the Hippo Pathway in Prostate Cancer.
Koinis F, Chantzara E, Samarinas M, Xagara A, Kratiras Z, Leontopoulou V, Kotsakis A. Koinis F, et al. Biomedicines. 2022 Nov 7;10(11):2834. doi: 10.3390/biomedicines10112834. Biomedicines. 2022. PMID: 36359354 Free PMC article. Review.
Salvage chemotherapy with docetaxel and pegylated liposomal doxorubicin in pretreated patients with platinum- and taxane-sensitive ovarian cancer: a multicenter phase II trial of the Hellenic Oncology Research Group (HORG).
Koinis F, Polyzos A, Christopoulou A, Zafeiriou Z, Emmanouilidis C, Papadimitraki E, Kalykaki A, Kalbakis K, Samonis G, Georgoulias V. Koinis F, et al. Cancer Chemother Pharmacol. 2014 Apr;73(4):819-25. doi: 10.1007/s00280-014-2411-2. Epub 2014 Feb 15. Cancer Chemother Pharmacol. 2014. PMID: 24531559 Clinical Trial.
Dynamic changes of CTCs in patients with metastatic HR(+)/HER2(-) breast cancer receiving salvage treatment with everolimus/exemestane.
Spiliotaki M, Kallergi G, Nikolaou C, Xenidis N, Politaki E, Apostolaki S, Georgoulia N, Koinis F, Tsoukalas N, Hatzidaki D, Kotsakis A, Georgoulias V. Spiliotaki M, et al. Among authors: koinis f. Cancer Chemother Pharmacol. 2021 Feb;87(2):277-287. doi: 10.1007/s00280-020-04227-5. Epub 2021 Jan 29. Cancer Chemother Pharmacol. 2021. PMID: 33515073
Prognostic significance of CEACAM5mRNA-positive circulating tumor cells in patients with metastatic colorectal cancer.
Messaritakis I, Sfakianaki M, Papadaki C, Koulouridi A, Vardakis N, Koinis F, Hatzidaki D, Georgoulia N, Kladi A, Kotsakis A, Souglakos J, Georgoulias V. Messaritakis I, et al. Among authors: koinis f. Cancer Chemother Pharmacol. 2018 Nov;82(5):767-775. doi: 10.1007/s00280-018-3666-9. Epub 2018 Aug 9. Cancer Chemother Pharmacol. 2018. PMID: 30094617
45 results